EXPRES2ION BIOTECHNOLOGIES ApS: Financial statements 2014
CVR: 32770487
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
EXPRES2ION BIOTECHNOLOGIES ApS (CVR 32770487) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 5,341,615 and a net result of DKK 225,540 compared with DKK 584,999 the year before. That is a decrease of 5.7% compared with the year before. Equity in the 2014 report amounted to DKK 1,836,710. The solvency ratio was 42.8%.
- Gross Profit
- DKK 5,341,615
- Profit/Loss
- DKK 225,540
- Equity
- DKK 1,836,710
- Total Assets
- DKK 4,289,306
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 5.3M | 226K | 1.8M | - |
| 2013 | - | 5.7M | 585K | 1.6M | - |
| 2012 | - | 1.6M | -1.8M | 1M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2013. Gross profit came to DKK 5,661,707, and the net result was DKK 584,999.
About EXPRES2ION BIOTECHNOLOGIES ApS
EXPRES2ION BIOTECHNOLOGIES ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ApS KBURS 17 NR. 6965. The management consists of Bent Ulrich Frandsen. The board consists of Martin Roland Jensen (chair), Jakob Ole Knudsen, Karin Garre and Michel Jean Baijot. The company is owned by Expres2ion Biotech Holding AB. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -9,158,236 and a net result of DKK -21,948,253 compared with DKK -19,830,535 the year before. Equity in the 2025 report amounted to DKK 23,950,262.